Clinical determinants of long-term survival in patients with glioblastoma multiforme

Tumori

Volumn 83, Issue 2, 1997, Pages 613-617

  Pollak, Lea ^a,b   Gur, Ruth ^a,b   Walach, Natalio ^a,b   Reif, Renata ^a,b   Tamir, Levia ^a,b   Schiffer, Juana ^a,b  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Glioblastoma multiforme; Long term survival

Indexed keywords

ADOLESCENT; ADULT; AGE; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CONFERENCE PAPER; FEMALE; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PROGNOSIS; SURVIVAL TIME;

EID: 0030787766     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089169708300228     Document Type: Conference Paper

References (29)

1. Adams E.D., Victor M.: Intracranial neoplasms. Principles of neurology, 5th ed, McGraw Hill Inc., New York, part IV, pp. 563-564, 1993.
2. Bauman G.S., Gaspar L.E., Fisher B.J., Halperin E.C,. MacDonald D.R., Cairncross J.G.: A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys., 29: 835-839, 1994.
3. Bindal A.K., Hammoud M., Shi W.M., Wu S.Z., Sawaya R., Rao J.S.: Prognostic significance of proteolytic enzymes in human brain tumors. J. Neurooncol., 22: 101-110, 1994.
4. Chandler K.L., Prados M.D., Malec M., Wilson C.B.: Longterm survival in patients with glioblastoma multiforme. Neurosurgery, 32: 716-720, 1993.
5. Coons S.W., Davis J.R., Way D.L.: Correlation of DNA content and histology in prognosis of astrocytomas. Am. J. Clin. Pathol., 90: 289-293, 1988.
6. Elvidge A.R.: Long-term survival in the astrocytoma series. J. Neurosurg., 28: 399-404, 1968.
7. Elvidge A.R., Barone B.M.: Long-term postoperative survival in two cases of glioblastoma multiforme. J. Neurosurg., 22: 382-386, 1965.
8. Fernandez P.M., Zamorano L., Yakar D., Gaspar L., Warmelink G.: Permanent iodine-125 implants in the up-front treatment of malignant gliomas. Neurosurgery, 36: 467-473, 1995.
9. Imperato J.P., Paleologos N.A., Vick N.A.: Effects of treatment on long-term survivors with malignant astrocytomas. Ann. Neurol., 28: 818-822, 1990.
10. Jeremic B., Grujicic D., Antunovic V., Djuric L., Stojanovic M., Shibamoto Y.: Influence of extent of surgery and tumor location on treatment outcome of patients with gliobastoma multiforme treated with combined modality approach. J. Neurooncol., 21: 177-185, 1994.
11. Kepes J.J., Rubinstein L.J., Ansbalher L., Schreiber D.J.: Histopathological features of recurrent pleomorphic xanthoastrocytomas: further corroboration of the glial nature of this neoplasm. A study of 3 cases. Acta. Neuropathol. Berl., 78: 585-593, 1989.
12. Krouwer H.G., Prados M.D.: Infiltrative astrocytomas of the thalamus. J. Neurosurg., 82: 548-557, 1995.
13. Kunwar S., Pai L.H., Pastan I.: Cytotoxicity and antitumor effects of growth factor-toxin fusion proteins on human glioblastoma multiforme cells. J. Neurosurg., 79: 569-576, 1993.
14. Lai D.M., Lin S.M., Tu Y.K., Kao M.C., Hung C.C.: Therapy for supratentorial malignant astrocytomas: Survival and possible prognostic factors. J. Formos. Med. Assoc., 92: 220-226, 1993.
15. Leon S.P., Zhu J., Black P.M.: Genetic aberrations in human brain tumors. Neurosurgery, 34: 708-722, 1994.
16. Longee D.C., Friedman H.S., Phillips P.C., Burger P.C., Oakes W.J., Heffez D., Wharam M., Strauss L., Fuller G.N., Schold S.C.: Osteoblastic metastases from astrocytomas: A report of two cases. Med. Pediatr. Oncol., 19: 318-324, 1991.
17. Mehta M.P., Mascipinto J., Rozental J., Levin A., Chappell R., Bastin K., Miles J., Turski P., Kubsad S., Mackie T.: Stereotactic radiosurgery for glioblastoma multiforme: Report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int. J. Radiat. Oncol. Biol. Phys., 30: 541-549, 1994.
18. Mikkelsen T, Yan P.S., Ho K.L., Sameni M., Sloane B.F., Rosenblum M.L.: Immunolocalization of cathepsin B in human glioma: implications for tumor invasion and angiogenesis. J. Neurosurg., 83: 285-290, 1995.
19. Murovic J., Turowski R., Wilson C.B., Hoschino T., Levin V.: Computerized tomography in the prognosis of malignant cerebral gliomas. J. Neurosurg., 65: 799-806, 1986.
20. Olson J.J., James C.D., Krisht A., Barnett D., Hunter S.: Analysis of epidermal growth factor receptor gene amplification and alteration in stereotactic biopsies of brain tumors. Neurosurgery, 36: 740-746, 1995.
21. Phuphanich S., Ferrall S., Greenberg H.: Long-term survival in malignant glioma. Prognostic factors. J. Fla. Med. Assoc., 80: 181-184, 1993.
22. Ritter A.M., Sawaya R., Hess K.R., Levin V.A., Bruner J.M.: Prognostic significance of bromodeoxyuridine labeling in primary and recurrent glioblastoma multiforme. Neurosurgery, 35: 192-198, 1994.
23. Rutz H.P., de Tribolet N., Calmes J.M., Chapuis G.: Longterm survival of a patient with glioblastoma and Turcot's syndrome. Case report. J. Neurosurg., 74: 813-815, 1991.
24. Salford L.G., Brun A., Nirfalk S.: Ten-year survival among patients with supratentorial astrocytomas grade III and IV. J. Neurosurg., 69: 506-509, 1988.
25. Shibamoto Y., Yamashita J., Takahashi M., Yamasaki T., Kikuchi H., Abe M.: Supratentorial malignant glioma: an analysis of radiation therapy in 178 cases. Radiother-Oncol., 18: 9-17, 1990.
26. Vertosick F.T., Selker R.G.: Long-term survival after the diagnosis of malignant glioma: A series of 22 patients surviving more than 4 years after diagnosis. Surg. Neurol., 38: 359-363, 1992.
27. Watkins D., Rouleau G.A.: Genetics, prognosis and therapy of central nervous system tumors. Cancer Detect. Prev., 18: 139-144, 1994.
28. Watne K., Nome D., Hager B., Hirschberg H.: Pre-radiation chemotherapy in glioma patients with poor prognostic fac-tors. J. Neurooncol., 13: 261-264, 1992.
29. Wurschmidt F., Bunemann H., Heilmann H.P.: Prognostic factors in high-grade malignant glioma. A multivariate analysis of 76 cases with postoperative radiotherapy. Strahlenther-Onkol., 171: 315-321, 1995.